Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated)
Clinical trial NCT00386425 · COMPLETED
Trial details
- NCT number
- NCT00386425
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2009-08-01
- Enrollment
- 486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.